Meribank Biotech Co., Ltd.

Meribank Biotech Co., Ltd. is a biotechnology company specializing in stem cell research, development, and storage in Taiwan. The company focuses on advanced cellular therapies, offering extensive services including the cryopreservation and application of placental and umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, immune cells, and peripheral blood stem cells. It supports both autologous and allogeneic stem cell storage and pursues innovations in stem cell processing and transplantation technology to expand therapeutic and regenerative medical applications. Meribank Biotech plays a key role in Taiwan’s healthcare sector, providing critical infrastructure for regenerative medicine, personalized treatments, and biotechnology advancements. Its operations primarily serve clients within Taiwan, contributing to the development and accessibility of stem cell therapies in the region. The company’s ongoing investment in cellular technology positions it as a vital participant in the growing field of biomedicine, with its services underpinning medical research, treatment, and long-term storage solutions for patients and healthcare providers.